Charles River Laboratories International (CRL) said Monday it has entered into a strategic collaboration with drug discovery firm X-Chem to boost its hit identification capabilities.
The partnership gives Charles River clients access to X-Chem's DNA-encoded library with more than 15 billion compounds, according to a statement.
Shares of Charles River were up more than 2% in recent trading Monday.
Price: 183.20, Change: +4.68, Percent Change: +2.62
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.